ABSTRACT
Introduction
Chronic liver inflammation caused by viral infections, alcohol and other toxic chemicals, and metabolic disorders is accompanied by tissue remodeling and fibrosis.
These interrelated pathological processes are major issues in hepatology because they are implicated in major clinical disorders, namely liver cirrhosis and carcinoma.
Previous studies have highlighted hepatic stellate cells (HSCs) as pivotal players contributing to liver fibrosis [1, 2] . Upon liver damage, HSCs transdifferentiate into myofibroblastic cells by inflammatory cytokines released mainly from Kupffer cells (KCs). Transformed HSCs are distinct from quiescent HSCs in terms of their proliferative activity, contractility facilitated by -smooth muscle actin (-SMA) expression, and production of collagens and other extracellular matrices. Since these properties contribute to the pathogenesis of liver fibrosis and cirrhosis, the molecular mechanism underlying myofibroblastic transformation of HSCs has been a research focus in this field. Septins are a family of cytoskeletal/scaffold proteins ubiquitously expressed in eukaryotic cells. Among the 13 septin genes shared by mice and humans, Sept4 is unique in that it is expressed in specific cells such as Bergmann glial cells in the 8 Pharma, Oslo, Norway) cushion. The density-separated HSCs were grown on uncoated dishes in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and antibiotics in 5% CO 2 at 37ºC. The purity of HSCs was consistently more than 98%, as assessed by the presence of lipid droplets and autofluorescence of vitamin A. We isolated hepatocytes as previously described [14] . In brief, the liver cells dispersed by infusing 0.03% collagenase in SC-2 solution were centrifuged at 50  g for 1 min. The cell pellet was washed twice by resuspending in GBSS-B solution (137 mM NaCl, 5.0 mM KCl, 1.0 mM MgCl 2 , 0.28 mM MgSO 4 , 0.84 mM NaH 2 PO 4 , 0.22 mM KH 2 PO 4 , 5.5 mM glucose, 2.7 mM NaHCO 3 , and 1.5 mM
CaCl [pH 7.25] ) and pelleting at 50  g for 1 min. We grew the fractionated hepatocytes using the same method as for HSCs, except that the dishes were coated with type I collagen.
Experimental liver fibrosis induced by carbon tetrachloride
As previously reported [5] , we injected carbon tetrachloride (CCl 4 ) (1.0 l/g body weight, 25% [v/v] in olive oil) or vehicle alone intraperitoneally into 6-week-old, male
Sept4
+/+ and Sept4 −/− mice, biweekly for 10 weeks.
Total RNA extraction and DNA microarray analysis
We prepared total RNA from HSCs at the 3 rd day in vitro (DIV3) using a phenol-chloroform extraction method (TRIzol; Invitrogen, Carlsbad, CA) and monitored the quality of total RNA from the elution profile of 18S and 28S ribosomal RNA [15] using the Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA). We amplified RNA (aRNA) samples using a T7-RNA polymerase system (TargetAmp 1-Round Aminoallyl aRNA amplification kit; Epicentre, Madison, WI) and labeled the aRNA samples using Cy5 Mono-Reactive Dye Pack (GE Healthcare, England). We hybridized DNA microarray chips (3D-Gene Mouse Oligo chip 24k; Toray, Tokyo, Japan) with Cy-5-labeled aRNA samples at 37ºC for 16 h and then washed the chips thoroughly. We scanned the hybridized chips and acquired chip image data using ProScanArray (Perkin Elmer, Waltham, MA). The scanned image data were processed using Genepix Pro 4.0 software (Molecular Devices, Sunnyvale, CA) to extract gene expression data, which were normalized using MATLAB software (Mathworks, Natick, MA) and a quantile normalization method [16] . For the above procedures, we followed the manufacturers' protocols with some modifications. We have registered the microarray data with NCBI's Gene Expression Omnibus (GEO) database under the accession number GSE24588.
Quantitative reverse transcription polymerase chain reaction analysis
Total RNA was extracted from liver samples or fractioned liver cells using TRIzol and reverse transcribed into cDNA using Omniscript RT Kit (QIAGEN, Germantown, MD) with random primers (Invitrogen). We conducted quantitative reverse transcription polymerase chain reaction (qRT-PCR) with gene-specific PCR primers (Table 1) and SYBR Green I Master reaction mix on a LightCycler 480 II (Roche Diagnostics, Basel, Switzerland). We quantified the relative abundance of each gene product against 18S as internal controls with the LightCycler 480 software (ver. 1.5).
Immunoblot analysis
We homogenized and sonicated cells or tissues in lysis buffer (50 mM Tris-HCl, 2% sodium dodecyl sulfate, and 10% glycerol), and centrifuged the homogenates at 15,000 × g for 10 min. After measuring the protein concentration and adding bromophenol blue (final concentration, 0.1%) and 2-mercaptoethanol (5%), each sample was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred onto a polyvinylidene fluoride (PVDF) membrane (Hybond-P, GE Healthcare), and probed with primary antibodies (anti-Dkk2, anti-desmin, anti-FLAG M2; SIGMA-Aldrich, St. Louis, MO; anti-albumin, BETHYL; Montgomery, TX, anti-PECAM-1, anti--actin; Santa Cruz Biotechnology, Santa Cruz, CA). After incubation with horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology) and chemiluminescence reaction with the ECL kit (GE Healthcare), we quantified the luminescence using an image analyzer, LAS-4000 (FujiFilm, Tokyo, Japan).
Construction of an expression plasmid for FLAG-Dkk2
We amplified the coding region of a mouse Dkk2 cDNA clone from the FANTOM collection (RIKEN) by PCR with a set of oligonucleotide primers, i.e., 5′-GAGAGAAGCTTTCACAGCTAGGCAGCTCG-3′ and 5′-CGGGATCCTCAGATCTTCTGGCATAC-3′. The HindIII-BamHI-digested fragment was inserted in-frame into the cognate sites of an expression plasmid, pFLAG-CMV1, (SIGMA-Aldrich) and the DNA sequence was confirmed. The FLAG-tag of this vector is preceded by a signal sequence for secretion and a signal peptidase cleavage site. We used the empty pFLAG-CMV1 plasmid as a control.
LX-2 cell culture, transfection, and FLAG-Dkk2 conditioned medium
We cultured 5.0  10 5 LX-2 cells [17] (a generous gift from Dr. Friedman and Dr.
Ikeda) per 60-mm dish in DMEM supplemented with 10% FBS. After about 24 h, we transfected the cells with the FLAG-Dkk2 or empty plasmid using FuGENE6 (Roche Diagnostics). We collected the culture supernatant (conditioned medium) containing recombinant FLAG-Dkk2 or FLAG-tag ~72 h after transfection.
Immunoprecipitation
We incubated the culture supernatant of the transfected LX-2 cells with anti-FLAG M2 antibody (SIGMA-Aldrich), followed by adsorption with Protein G Sepharose beads (GE Healthcare) for 2 h. After washing the beads 3 times with TNE buffer (10 mM Tris-HCl at pH 7.8, 1% NP40, 0.15 M NaCl, and 1 mM EDTA), we subjected the immunoprecipitates to immunoblot analysis as described above (section 2.6.). 
Luciferase assay

Immunohistochemistry of human liver tissues
We procured human tissue specimens of livers afflicted with chronic hepatitis, liver fibrosis, or liver cirrhosis from the Department of Surgery, Kyoto University
Hospital. All samples were obtained with the patients' informed consent. We immunostained paraffin sections with anti-Dkk2 antibody (Abcam, Cambridge, UK) as described previously [5, 14] and observed them under a digital microscope (BZ-9000; binding to and internalizing LRP5/6, a co-receptor of Fzd [10] [11] [12] . Previous studies showed that some Dkks are implicated in the negative regulation of Wnt-mediated cell proliferation, inflammation, and/or pro-fibrotic reactions in diverse tissues, including the liver [8, 9, 19] .
Loss of Sept4 suppresses upregulation of Dkk1, 2, 3 in an in vivo model of hepatitis/fibrosis
We tested whether the reduced Dkk2 expression in cultured Sept4 −/− HSCs is an in vitro artifact or a pathologically relevant recapitulation of a molecular event during hepatitis and fibrosis. We applied the CCl 4 model of hepatitis/fibrosis to Sept4 −/− and Sept4 +/+ mice as reported previously [5] , and quantified the expression levels of 3 major
Dkk genes expressed in the liver by qRT-PCR. While the basal expression levels of Dkk1-3 were comparable between the 2 genotypes (controls in Fig. 2A -C), their upregulation after CCl 4 -induced liver damage was diminished in the absence of Sept4.
Concordantly, the reduction of Dkk2 upregulation in Sept4 −/− liver was observed at the protein level (Fig. 2D ). Since Dkks are responsible for the suppressive modulation of Wnt-mediated inflammatory/fibrotic processes [8] , their reduction in Sept4 -/-liver may contribute to the enhanced pathological reaction shown previously [5] .
HSCs are the major source of Dkk1-3 in the liver
To identify the origin of upregulated were almost exclusively expressed in HSCs, indicating that HSCs are the major source of Dkk1-3 secreted in the liver, but hepatocytes and the other cell types are not ( Fig.3 A-C, and data not shown). Concordantly, immunoblot analysis showed that Dkk2 protein was almost exclusively expressed in HSCs, but not in hepatocytes, ECs, and KCs (Fig. 3D ). Since Sept4 is also expressed exclusively in HSCs in the liver [5] , the diminished upregulation of Dkk1-3 is likely to be a cell-autonomous, if not a direct, consequence of the loss of Sept4.
Loss of Sept4 suppresses robust upregulation of Dkk2/3 through myofibroblastic transformation of HSCs in vitro
So far, we have demonstrated that the upregulation of Dkk1-3 is an HSC-specific, pathologically relevant event that may antagonize the inflammatory/fibrotic processes mediated by the Wnt pathway. To test whether the 3 major Dkk genes are differentially regulated during myofibroblastic transformation, we examined the time course of their expression in HSCs cultured in vitro for 1-5 days by qRT-PCR (Fig. 4) . Consistent with the in vivo results (Fig. 2 ), Dkk2 and Dkk3 were remarkably upregulated in this in vitro model, and more importantly, the upregulation was significantly diminished in Sept4 -/-HSCs.
Dkk2 interferes with the canonical Wnt pathway in human HSC-derived cells
Because Dkks are secretory proteins that interact with the Wnt-Fzd complex [7, 20] , it is important to test whether or not Dkks produced by HSCs can act on HSCs in an autocrine/paracrine manner. Since primary cultured HSCs are unsuitable for the following assay which requires a high transfection efficiency, we employed a human HSC-derived cell line, LX-2 [17] . We transfected LX-2 cells either with a FLAG-tagged mouse Dkk2 expression plasmid or with an empty (FLAG-tag alone) plasmid, which served as a control. The culture supernatant from each condition was collected 3 days after transfection, immunoprecipitated with an anti-FLAG M2 antibody, and immunoblotted for Dkk2. The immunoblot showed a 28-kDa polypeptide for FLAG-Dkk2 secreted into the medium (Fig. 5A ).
To test whether Dkk2 could interfere with the canonical Wnt signaling pathway in HSCs, we transfected LX-2 cells with a TOP-Flash reporter plasmid, which is designed to monitor the activity of the canonical Wnt pathway through Lef/Tcf-mediated luciferase gene expression [18] . The reporter-transfected LX-2 cells were supplemented with the aforementioned conditioned medium with or without FLAG-Dkk2. Compared with the control medium, the FLAG-Dkk2-containing medium significantly suppressed the luciferase activity of LX-2 cells measured 2 days later (Fig. 5B) . Taken together, these data indicate that Dkks secreted from HSCs act on HSCs in an autocrine/paracrine manner and interfere with the canonical Wnt pathway, which is known to drive myofibroblastic transformation [9] . However, these data do not exclude the possibility that Dkks suppress the non-canonical Wnt signaling pathways in HSCs or act on other cell types in the liver.
Dkk2 interferes with pro-fibrotic transformation of Sept4 -/-HSCs
On the basis of the above results, we examined whether supplementing exogenous (Fig. 6) . Concordantly, one-shot supplementation of recombinant Dkk2 (nominal concentration, 5 g/ml [184 nM]) gave similar but less significant results, partly due to its low actual potency and/or rapid clearance (Suppl. Fig 1) . These data indicate that continuous supplementation with Dkk2 can partially suppress the myofibroblastic transformation of Sept4 -/-HSCs by interfering with the canonical Wnt signaling pathway that transactivates pro-fibrotic genes and suppresses the expression of anti-fibrotic genes.
Status of Dkk2 in human HSCs under pathological conditions
We assessed the clinical relevance of our findings by determining the status of Dkk2 in pathological human liver specimens using immunohistochemistry. There was a gradual increment of Dkk2-immunoreactivity from normal liver tissue, hepatitis, mild fibrosis through to cirrhosis (Fig. 7A-D) . Dkk2-positive cells were detected almost exclusively in the perisinusoidal spaces where HSCs reside, and appeared to increase in number as fibrosis progressed. These data conform to the hypothesis that the upregulation of Dkk2 in HSCs is a common counteractive mechanism against fibrotic processes in liver diseases.
Discussion
This study derived from an open question raised by our previous findings [5] , which included the determination of the mechanism that renders Sept4 -/-mice prone to liver fibrosis. Genome-wide expression profiling and qRT-PCR analysis revealed that a number of genes in HSCs are expressed differently in the absence of Sept4. We hypothesized that these include genes responsible for the fibrosis-prone phenotype. In this report, we focused on the reduced expression of the anti-fibrotic genes Dkk1-3 in Table 2A and B), although their contribution has not been assessed in this study.
The molecular network of Wnt signaling consists of 3 major pathways, i.e., the canonical Wnt/-catenin pathway, the Wnt/Ca 2+ pathway, and the planar cell polarity-convergent extension pathway. The canonical Wnt pathway plays a critical role in developmental morphogenesis and homeostatic tissue remodeling by controlling cell proliferation and differentiation [7, 11] . Hence, dysregulation of this pathway is known to cause cancer [21] , aberrant tissue remodeling [22, 23] , and fibrosis [6] . This pathway is activated when Wnt binds to its cognate receptor Fzd, which interacts with the glycogen synthase kinase-3 -mediated phosphorylation and the subsequent degradation of -catenin. When -catenin translocates to the nucleus, it activates the transcription factor Lef/Tcf and alters the gene expression pattern. Dkks interact with the canonical Wnt pathway by binding to and facilitating the internalization of LRP5/6, a co-receptor of Fzd [10] . Among the 3 major Dkk family members expressed in HSCs, Dkk1 consistently antagonizes the canonical Wnt pathway, while Dkk2 can be either an antagonist or an agonist, depending on the presence or absence of another Wnt co-receptor, Kremen1/2 [24] . The expression of Kremen1/2 in HSCs (Suppl. Fig. 2 ) is consistent with the antagonistic function of Dkk2 in the canonical Wnt pathway (Fig. 5) .
Thus, Dkk1/2 may antagonize the canonical Wnt pathway in HSCs, though the function of Dkk3 is currently unclear.
Open questions also include the molecular mechanism that links loss of Sept4 and reduced transactivation of the Dkk genes (Fig. 8) . Since Sept4 is a subunit of the septin heteropolymers associated mainly with other cytoskeletal and submembranous components (see Fig. 1 [5] ), its direct interaction with the transcription machinery is unlikely. In some human cell lines, however, depletion of the Sept7 subunit can release suppressor of cytokine signaling 7 (SOCS7) from septin heteropolymers in the cytoplasm, which promotes the translocation of the non-catalytic region of tyrosine kinase adaptor protein (NCK) to the nucleus and activates the DNA damage checkpoint machinery [25] . Thus, genetic loss of Sept4 could also indirectly alter nuclear events.
Another scenario similar to the scarcity of the dopamine transporter in Sept4
−/− dopamine neurons [3] is that some proteins responsible for anti-fibrotic signaling could be destabilized by the loss of septin-based scaffolds in Sept4 −/− HSCs. Narrowing down the molecular mechanism from these and other possibilities should give us a clearer picture of myofibroblastic transformation of HSCs in liver fibrosis.
Supplementary materials related to this article can be found online 412 at doi:10.1016/j.bbadis.2011.06.015.
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